Table 3 Base case analysis
From: Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
Strategy | Cost ($) | Effectiveness (QALYs) | Marginal Cost ($) | Marginal Effectiveness (QALYs) | Marg C/E ratio (Δ$/ΔQALYs) |
|---|---|---|---|---|---|
rFVIIa | $39,305 | 0. 40 | |||
Usual Care | $40,359 | 0. 29 | $1,053. 20 | -0. 11 | ******** |